|
Randomized Controlled Trial
Citations 291-300 of 820 total displayed.
|
Past content
(since Jan 1999):
|
- Letters
Implications of Disclosing Individual Results of Clinical Research—Reply
- David I. Shalowitz; Franklin G. Miller
JAMA 2006; 295: 37-a-38-a.
[Extract]
[Full text]
[PDF]
- Letters
Implications of Disclosing Individual Results of Clinical Research
- Ellen Wright Clayton; Lainie Friedman Ross
JAMA 2006; 295: 37.
[Extract]
[Full text]
[PDF]
- Original Contributions
L-Arginine Therapy in Acute Myocardial Infarction: The Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) Randomized Clinical Trial
- Steven P. Schulman; Lewis C. Becker; David A. Kass; Hunter C. Champion; Michael L. Terrin; Sandra Forman; Kavita V. Ernst; Mark D. Kelemen; Susan N. Townsend; Anne Capriotti; Joshua M. Hare; Gary Gerstenblith
JAMA 2006; 295: 58-64.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: A Randomized Controlled Trial
- L. Brent Mitchell; Derek V. Exner; D. George Wyse; Carol J. Connolly; Gregory D. Prystai; Alexander J. Bayes; William T. Kidd; Teresa Kieser; John J. Burgess; André Ferland; Charles L. MacAdams; Andrew Maitland
JAMA 2005; 294: 3093-3100.
[Abstract]
[Full text]
[PDF]
- Letters
Contradictions in Highly Cited Clinical Research
- Peter Westfall; S. Stanley Young
JAMA 2005; 294: 2695-b-2696-b.
[Extract]
[Full text]
[PDF]
- Letters
Contradictions in Highly Cited Clinical Research
- Paul S. Heckerling
JAMA 2005; 294: 2695-a.
[Extract]
[Full text]
[PDF]
- Letters
Contradictions in Highly Cited Clinical Research
- Colin P. West
JAMA 2005; 294: 2695.
[Extract]
[Full text]
[PDF]
- Letters
Contradictions in Highly Cited Clinical Research—Reply
- John P. A. Ioannidis
JAMA 2005; 294: 2696.
[Extract]
[Full text]
[PDF]
- Original Contributions
High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction: The IDEAL Study: A Randomized Controlled Trial
- Terje R. Pedersen; Ole Faergeman; John J. P. Kastelein; Anders G. Olsson; Matti J. Tikkanen; Ingar Holme; Mogens Lytken Larsen; Fredrik S. Bendiksen; Christina Lindahl; Michael Szarek; John Tsai; for the Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group
JAMA 2005; 294: 2437-2445.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Efficacy and Safety of Edifoligide, an E2F Transcription Factor Decoy, for Prevention of Vein Graft Failure Following Coronary Artery Bypass Graft Surgery: PREVENT IV: A Randomized Controlled Trial
- PREVENT IV Investigators
JAMA 2005; 294: 2446-2454.
[Abstract]
[Full text]
[PDF]
|
|
